Position in FATE
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$59,310
+$35,897 QoQ
Shares Held
49,425
+106.9% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 0.8194233687405159.ToString("F0")%
Shared 0.ToString("F0")%
None 99.18057663125948.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Derivatives in FATE
reported options exposure · as of Jun 30, 2020CallValue
$6,862
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Creative Planning holds $360,319,340 across 212 Biotechnology names. FATE ranks #190 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
109,524 | $48,906,846 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
40,152 | $31,023,040 | |
| 3 | INSM |
INSMED Inc
|
72,200 | $11,806,143 | |
| 4 | EXEL |
Exelixis, Inc.
|
234,142 | $10,042,350 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
119,661 | $8,886,025 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
140,177 | $8,145,685 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
24,122 | $7,981,245 | |
| 8 | INCY |
Incyte Corp
|
80,874 | $7,611,860 |
All Filings in FATE
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,310 | 49,425 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $23,413 | 23,891 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $33,130 | 26,294 | Shares | Sole | 2025-11-14 | |
| 2021-03-31 | $344,228 | 4,175 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $558,855 | 6,146 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $269,157 | 6,734 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $264,770 | 7,717 | Shares | Sole | 2020-07-23 | |
| 2020-06-30 | $6,862 | 200 | Call | Sole | 2020-07-23 | |
| No filing history on record for this holder in this stock. | ||||||